The presence of persistent hypoparathyroidism should prompt physicians to consider a possible diagnosis of autoimmune polyglandular syndrome type 1 (APS-1),…
Articles by Joana Carvalho, PhD
Ascendis Pharma anticipates it will announce top-line data from a new Phase 3 clinical trial of TransCon PTH, the…
The specific surgical procedures used when patients undergo thyroid surgery — known as thyroidectomy — dictate the risks they…
People with hypoparathyroidism who wish to undergo weight-loss surgery should consider possible difficulties in maintaining calcium levels within…
People with hypoparathyroidism living in the U.S. still struggle to receive proper medical care, particularly during emergency room visits,…
Patients with DiGeorge syndrome tend to experience hypoparathyroidism symptoms earlier — and ones that are milder — compared to those…
Careful identification and dissection of the parathyroid glands during thyroid surgery can reduce the risk of…
The pharmacological properties of hPTH(1-34) allow the oral medication to be administered at different dosing regimens to suit the…
Researchers may have found a way to decrease the risks of temporary or permanent hypoparathyroidism following thyroid surgery.
Takeda has issued a U.S. recall of its prescription parathyroid hormone Natpara, due to the potential risk of…